世界のニューロペプチドY受容体市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Neuropeptide Y Receptor Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z09920 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：食品・飲料

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、ニューロペプチドY受容体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ニューロペプチドY受容体の種類別市場規模（食品用、医薬品用）、用途別市場規模（医薬品、食品添加物、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ニューロペプチドY受容体の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Gila Therapeutics、Novo Nordisk、XL-protein、Lilly Eli、Novartis、Pfizer、Merck & Co、Mannkind、Gilead Sciences、Genentech ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：食品用、医薬品用 ・用途別分析2016年-2026年：医薬品、食品添加物、その他 ・ニューロペプチドY受容体の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ニューロペプチドY受容体のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ニューロペプチドY受容体のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ニューロペプチドY受容体の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ニューロペプチドY受容体の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Neuropeptide Y Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Neuropeptide Y Receptor size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Neuropeptide Y Receptor market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Neuropeptide Y Receptor market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Food Grade
Pharmaceutical Grade

Market segment by Application can be divided into
Medicine
Food Additives
Others

The key market players for global Neuropeptide Y Receptor market are listed below:
Gila Therapeutics
Novo Nordisk
XL-protein
Lilly Eli
Novartis
Pfizer
Merck & Co
Mannkind
Gilead Sciences
Genentech

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Neuropeptide Y Receptor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuropeptide Y Receptor Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Food Grade
1.2.3 Pharmaceutical Grade
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuropeptide Y Receptor Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Medicine
1.3.3 Food Additives
1.3.4 Others
1.4 Global Neuropeptide Y Receptor Market Size & Forecast
1.4.1 Global Neuropeptide Y Receptor Sales in Value (2016-2026))
1.4.2 Global Neuropeptide Y Receptor Sales in Volume (2016-2026)
1.4.3 Global Neuropeptide Y Receptor Price by Type (2016-2026) & (US$/Ton)
1.5 Global Neuropeptide Y Receptor Production Capacity Analysis
1.5.1 Global Neuropeptide Y Receptor Total Production Capacity (2016-2026)
1.5.2 Global Neuropeptide Y Receptor Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neuropeptide Y Receptor Market Drivers
1.6.2 Neuropeptide Y Receptor Market Restraints
1.6.3 Neuropeptide Y Receptor Trends Analysis
2 Manufacturers Profiles
2.1 Gila Therapeutics
2.1.1 Gila Therapeutics Details
2.1.2 Gila Therapeutics Major Business
2.1.3 Gila Therapeutics Neuropeptide Y Receptor Product and Services
2.1.4 Gila Therapeutics Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novo Nordisk
2.2.1 Novo Nordisk Details
2.2.2 Novo Nordisk Major Business
2.2.3 Novo Nordisk Neuropeptide Y Receptor Product and Services
2.2.4 Novo Nordisk Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 XL-protein
2.3.1 XL-protein Details
2.3.2 XL-protein Major Business
2.3.3 XL-protein Neuropeptide Y Receptor Product and Services
2.3.4 XL-protein Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Lilly Eli
2.4.1 Lilly Eli Details
2.4.2 Lilly Eli Major Business
2.4.3 Lilly Eli Neuropeptide Y Receptor Product and Services
2.4.4 Lilly Eli Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Neuropeptide Y Receptor Product and Services
2.5.4 Novartis Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Neuropeptide Y Receptor Product and Services
2.6.4 Pfizer Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Merck & Co
2.7.1 Merck & Co Details
2.7.2 Merck & Co Major Business
2.7.3 Merck & Co Neuropeptide Y Receptor Product and Services
2.7.4 Merck & Co Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Mannkind
2.8.1 Mannkind Details
2.8.2 Mannkind Major Business
2.8.3 Mannkind Neuropeptide Y Receptor Product and Services
2.8.4 Mannkind Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Gilead Sciences
2.9.1 Gilead Sciences Details
2.9.2 Gilead Sciences Major Business
2.9.3 Gilead Sciences Neuropeptide Y Receptor Product and Services
2.9.4 Gilead Sciences Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Genentech
2.10.1 Genentech Details
2.10.2 Genentech Major Business
2.10.3 Genentech Neuropeptide Y Receptor Product and Services
2.10.4 Genentech Neuropeptide Y Receptor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Neuropeptide Y Receptor Sales by Manufacturer
3.1 Global Neuropeptide Y Receptor Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Neuropeptide Y Receptor Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Neuropeptide Y Receptor
3.4 Market Concentration Rate
3.4.1 Top 3 Neuropeptide Y Receptor Manufacturer Market Share
3.4.2 Top 6 Neuropeptide Y Receptor Manufacturer Market Share
3.5 Global Neuropeptide Y Receptor Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Neuropeptide Y Receptor Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Neuropeptide Y Receptor Market Size by Region
4.1.1 Global Neuropeptide Y Receptor Sales in Volume by Region (2016-2026)
4.1.2 Global Neuropeptide Y Receptor Revenue by Region (2016-2026)
4.2 North America Neuropeptide Y Receptor Revenue (2016-2026)
4.3 Europe Neuropeptide Y Receptor Revenue (2016-2026)
4.4 Asia-Pacific Neuropeptide Y Receptor Revenue (2016-2026)
4.5 South America Neuropeptide Y Receptor Revenue (2016-2026)
4.6 Middle East and Africa Neuropeptide Y Receptor Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Neuropeptide Y Receptor Sales in Volume by Type (2016-2026)
5.2 Global Neuropeptide Y Receptor Revenue by Type (2016-2026)
5.3 Global Neuropeptide Y Receptor Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Neuropeptide Y Receptor Sales in Volume by Application (2016-2026)
6.2 Global Neuropeptide Y Receptor Revenue by Application (2016-2026)
6.3 Global Neuropeptide Y Receptor Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Neuropeptide Y Receptor Sales by Type (2016-2026)
7.2 North America Neuropeptide Y Receptor Sales by Application (2016-2026)
7.3 North America Neuropeptide Y Receptor Market Size by Country
7.3.1 North America Neuropeptide Y Receptor Sales in Volume by Country (2016-2026)
7.3.2 North America Neuropeptide Y Receptor Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Neuropeptide Y Receptor Sales by Type (2016-2026)
8.2 Europe Neuropeptide Y Receptor Sales by Application (2016-2026)
8.3 Europe Neuropeptide Y Receptor Market Size by Country
8.3.1 Europe Neuropeptide Y Receptor Sales in Volume by Country (2016-2026)
8.3.2 Europe Neuropeptide Y Receptor Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Neuropeptide Y Receptor Sales by Type (2016-2026)
9.2 Asia-Pacific Neuropeptide Y Receptor Sales by Application (2016-2026)
9.3 Asia-Pacific Neuropeptide Y Receptor Market Size by Region
9.3.1 Asia-Pacific Neuropeptide Y Receptor Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Neuropeptide Y Receptor Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Neuropeptide Y Receptor Sales by Type (2016-2026)
10.2 South America Neuropeptide Y Receptor Sales by Application (2016-2026)
10.3 South America Neuropeptide Y Receptor Market Size by Country
10.3.1 South America Neuropeptide Y Receptor Sales in Volume by Country (2016-2026)
10.3.2 South America Neuropeptide Y Receptor Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Neuropeptide Y Receptor Sales by Type (2016-2026)
11.2 Middle East & Africa Neuropeptide Y Receptor Sales by Application (2016-2026)
11.3 Middle East & Africa Neuropeptide Y Receptor Market Size by Country
11.3.1 Middle East & Africa Neuropeptide Y Receptor Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Neuropeptide Y Receptor Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Neuropeptide Y Receptor Typical Distributors
12.3 Neuropeptide Y Receptor Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Neuropeptide Y Receptor Revenue by Type, (USD Million), 2021-2026
Table 2. Global Neuropeptide Y Receptor Revenue by Application, (USD Million), 2021-2026
Table 3. Gila Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Gila Therapeutics Major Business
Table 5. Gila Therapeutics Neuropeptide Y Receptor Product and Services
Table 6. Gila Therapeutics Neuropeptide Y Receptor Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 8. Novo Nordisk Major Business
Table 9. Novo Nordisk Neuropeptide Y Receptor Product and Services
Table 10. Novo Nordisk Neuropeptide Y Receptor Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. XL-protein Basic Information, Manufacturing Base and Competitors
Table 12. XL-protein Major Business
Table 13. XL-protein Neuropeptide Y Receptor Product and Services
Table 14. XL-protein Neuropeptide Y Receptor Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Lilly Eli Basic Information, Manufacturing Base and Competitors
Table 16. Lilly Eli Major Business
Table 17. Lilly Eli Neuropeptide Y Receptor Product and Services
Table 18. Lilly Eli Neuropeptide Y Receptor Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis Neuropeptide Y Receptor Product and Services
Table 22. Novartis Neuropeptide Y Receptor Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Neuropeptide Y Receptor Product and Services
Table 26. Pfizer Neuropeptide Y Receptor Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 28. Merck & Co Major Business
Table 29. Merck & Co Neuropeptide Y Receptor Product and Services
Table 30. Merck & Co Neuropeptide Y Receptor Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Mannkind Basic Information, Manufacturing Base and Competitors
Table 32. Mannkind Major Business
Table 33. Mannkind Neuropeptide Y Receptor Product and Services
Table 34. Mannkind Neuropeptide Y Receptor Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 36. Gilead Sciences Major Business
Table 37. Gilead Sciences Neuropeptide Y Receptor Product and Services
Table 38. Gilead Sciences Neuropeptide Y Receptor Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Genentech Basic Information, Manufacturing Base and Competitors
Table 40. Genentech Major Business
Table 41. Genentech Neuropeptide Y Receptor Product and Services
Table 42. Genentech Neuropeptide Y Receptor Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Neuropeptide Y Receptor Sales by Manufacturer (2019-2021e) & (Kiloton)
Table 44. Global Neuropeptide Y Receptor Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Neuropeptide Y Receptor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Neuropeptide Y Receptor Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 47. Head Office and Neuropeptide Y Receptor Production Site of Key Manufacturer
Table 48. Global Neuropeptide Y Receptor Sales by Region (2016-2021e) & (Kiloton)
Table 49. Global Neuropeptide Y Receptor Sales by Region (2021-2026) & (Kiloton)
Table 50. Global Neuropeptide Y Receptor Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Neuropeptide Y Receptor Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Neuropeptide Y Receptor Sales by Type (2016-2021e) & (Kiloton)
Table 53. Global Neuropeptide Y Receptor Sales by Type (2021-2026) & (Kiloton)
Table 54. Global Neuropeptide Y Receptor Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Neuropeptide Y Receptor Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Neuropeptide Y Receptor Price by Type (2016-2021e) & (US$/Ton)
Table 57. Global Neuropeptide Y Receptor Price by Type (2021-2026) & (US$/Ton)
Table 58. Global Neuropeptide Y Receptor Sales by Application (2016-2021e) & (Kiloton)
Table 59. Global Neuropeptide Y Receptor Sales by Application (2021-2026) & (Kiloton)
Table 60. Global Neuropeptide Y Receptor Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Neuropeptide Y Receptor Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Neuropeptide Y Receptor Price by Application (2016-2021e) & (US$/Ton)
Table 63. Global Neuropeptide Y Receptor Price by Application (2021-2026) & (US$/Ton)
Table 64. North America Neuropeptide Y Receptor Sales by Country (2016-2021e) & (Kiloton)
Table 65. North America Neuropeptide Y Receptor Sales by Country (2021-2026) & (Kiloton)
Table 66. North America Neuropeptide Y Receptor Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Neuropeptide Y Receptor Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Neuropeptide Y Receptor Sales by Type (2016-2021e) & (Kiloton)
Table 69. North America Neuropeptide Y Receptor Sales by Type (2021-2026) & (Kiloton)
Table 70. North America Neuropeptide Y Receptor Sales by Application (2016-2021e) & (Kiloton)
Table 71. North America Neuropeptide Y Receptor Sales by Application (2021-2026) & (Kiloton)
Table 72. Europe Neuropeptide Y Receptor Sales by Country (2016-2021e) & (Kiloton)
Table 73. Europe Neuropeptide Y Receptor Sales by Country (2021-2026) & (Kiloton)
Table 74. Europe Neuropeptide Y Receptor Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Neuropeptide Y Receptor Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Neuropeptide Y Receptor Sales by Type (2016-2021e) & (Kiloton)
Table 77. Europe Neuropeptide Y Receptor Sales by Type (2021-2026) & (Kiloton)
Table 78. Europe Neuropeptide Y Receptor Sales by Application (2016-2021e) & (Kiloton)
Table 79. Europe Neuropeptide Y Receptor Sales by Application (2021-2026) & (Kiloton)
Table 80. Asia-Pacific Neuropeptide Y Receptor Sales by Region (2016-2021e) & (Kiloton)
Table 81. Asia-Pacific Neuropeptide Y Receptor Sales by Region (2021-2026) & (Kiloton)
Table 82. Asia-Pacific Neuropeptide Y Receptor Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Neuropeptide Y Receptor Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Neuropeptide Y Receptor Sales by Type (2016-2021e) & (Kiloton)
Table 85. Asia-Pacific Neuropeptide Y Receptor Sales by Type (2021-2026) & (Kiloton)
Table 86. Asia-Pacific Neuropeptide Y Receptor Sales by Application (2016-2021e) & (Kiloton)
Table 87. Asia-Pacific Neuropeptide Y Receptor Sales by Application (2021-2026) & (Kiloton)
Table 88. South America Neuropeptide Y Receptor Sales by Country (2016-2021e) & (Kiloton)
Table 89. South America Neuropeptide Y Receptor Sales by Country (2021-2026) & (Kiloton)
Table 90. South America Neuropeptide Y Receptor Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Neuropeptide Y Receptor Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Neuropeptide Y Receptor Sales by Type (2016-2021e) & (Kiloton)
Table 93. South America Neuropeptide Y Receptor Sales by Type (2021-2026) & (Kiloton)
Table 94. South America Neuropeptide Y Receptor Sales by Application (2016-2021e) & (Kiloton)
Table 95. South America Neuropeptide Y Receptor Sales by Application (2021-2026) & (Kiloton)
Table 96. Middle East & Africa Neuropeptide Y Receptor Sales by Country (2016-2021e) & (Kiloton)
Table 97. Middle East & Africa Neuropeptide Y Receptor Sales by Country (2021-2026) & (Kiloton)
Table 98. Middle East & Africa Neuropeptide Y Receptor Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Neuropeptide Y Receptor Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Neuropeptide Y Receptor Sales by Type (2016-2021e) & (Kiloton)
Table 101. Middle East & Africa Neuropeptide Y Receptor Sales by Type (2021-2026) & (Kiloton)
Table 102. Middle East & Africa Neuropeptide Y Receptor Sales by Application (2016-2021e) & (Kiloton)
Table 103. Middle East & Africa Neuropeptide Y Receptor Sales by Application (2021-2026) & (Kiloton)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Neuropeptide Y Receptor Typical Distributors
Table 107. Neuropeptide Y Receptor Typical Customers
List of Figures
Figure 1. Neuropeptide Y Receptor Picture
Figure 2. Global Neuropeptide Y Receptor Sales Market Share by Type in 2020
Figure 3. Food Grade
Figure 4. Pharmaceutical Grade
Figure 5. Global Neuropeptide Y Receptor Sales Market Share by Application in 2020
Figure 6. Medicine
Figure 7. Food Additives
Figure 8. Others
Figure 9. Global Neuropeptide Y Receptor Market Size, (USD Million) & (Kiloton): 2020 VS 2021 VS 2026
Figure 10. Global Neuropeptide Y Receptor Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Neuropeptide Y Receptor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Neuropeptide Y Receptor Sales (2016-2026) & (Kiloton)
Figure 31. Global Neuropeptide Y Receptor Production Capacity (2016-2026) & (Kiloton)
Figure 32. Global Neuropeptide Y Receptor Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Neuropeptide Y Receptor Market Drivers
Figure 34. Neuropeptide Y Receptor Market Restraints
Figure 35. Neuropeptide Y Receptor Market Trends
Figure 36. Global Neuropeptide Y Receptor Sales Market Share by Manufacturer in 2020
Figure 37. Global Neuropeptide Y Receptor Revenue Market Share by Manufacturer in 2020
Figure 38. Neuropeptide Y Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Neuropeptide Y Receptor Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Neuropeptide Y Receptor Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Neuropeptide Y Receptor Sales Market Share by Region (2016-2026)
Figure 42. Global Neuropeptide Y Receptor Revenue Market Share by Region (2016-2026)
Figure 43. North America Neuropeptide Y Receptor Revenue (2016-2026) & (USD Million)
Figure 44. Europe Neuropeptide Y Receptor Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Neuropeptide Y Receptor Revenue (2016-2026) & (USD Million)
Figure 46. South America Neuropeptide Y Receptor Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Neuropeptide Y Receptor Revenue (2016-2026) & (USD Million)
Figure 48. Global Neuropeptide Y Receptor Sales Market Share by Type (2016-2026)
Figure 49. Global Neuropeptide Y Receptor Revenue Market Share by Type (2016-2026)
Figure 50. Global Neuropeptide Y Receptor Price by Type (2016-2026) & (US$/Ton)
Figure 51. Global Neuropeptide Y Receptor Sales Market Share by Application (2016-2026)
Figure 52. Global Neuropeptide Y Receptor Revenue Market Share by Application (2016-2026)
Figure 53. Global Neuropeptide Y Receptor Price by Application (2016-2026) & (US$/Ton)
Figure 54. North America Neuropeptide Y Receptor Sales Market Share by Country (2016-2026)
Figure 55. North America Neuropeptide Y Receptor Revenue Market Share by Country (2016-2026)
Figure 56. North America Neuropeptide Y Receptor Sales Market Share by Type (2016-2026)
Figure 57. North America Neuropeptide Y Receptor Sales Market Share by Application (2016-2026)
Figure 58. Europe Neuropeptide Y Receptor Sales Market Share by Country (2016-2026)
Figure 59. Europe Neuropeptide Y Receptor Revenue Market Share by Country (2016-2026)
Figure 60. Europe Neuropeptide Y Receptor Sales Market Share by Type (2016-2026)
Figure 61. Europe Neuropeptide Y Receptor Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Neuropeptide Y Receptor Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Neuropeptide Y Receptor Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Neuropeptide Y Receptor Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Neuropeptide Y Receptor Sales Market Share by Application (2016-2026)
Figure 66. South America Neuropeptide Y Receptor Sales Market Share by Country (2016-2026)
Figure 67. South America Neuropeptide Y Receptor Revenue Market Share by Country (2016-2026)
Figure 68. South America Neuropeptide Y Receptor Sales Market Share by Type (2016-2026)
Figure 69. South America Neuropeptide Y Receptor Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Neuropeptide Y Receptor Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Neuropeptide Y Receptor Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Neuropeptide Y Receptor Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Neuropeptide Y Receptor Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source

---